Key result
MASLD affects ~70% of US adolescents with obesity, with overall disease prevalence reaching ~20%.
Cross-Sectional
Yes
Authors
No takes yet. Share an insight, caveat, or question.
The prevalence of MASLD and obesity among US adolescents has risen significantly from 1999 to 2020, affecting approximately 20% of adolescents and 70% of those with obesity by 2017-2020.
Sun et al. (2025) conducted a cross-sectional in Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Obesity was evaluated on Prevalence of obesity and MASLD (2017-2020). Between 2017 and 2020, the prevalence of obesity and MASLD among US adolescents was approximately 20%, with about 70% of obese adolescents affected by MASLD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: